Status: current, Defined. Date: 31-Oct 2018. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2804981000168112 | Lymph-Flo Hydrochloric Acid (hydrochloric acid 36.458 mg / 1 mL) injection, 1 x 1 mL vial (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
2804991000168110 | Lymph-Flo Hydrochloric Acid 1 Molar injection, 1 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Lymph-Flo Hydrochloric Acid 1 Molar injection, 1 mL vial | Is a | Lymph-Flo Hydrochloric Acid 1 Molar injection, 1 mL vial | true | Inferred relationship | Some | ||
Lymph-Flo Hydrochloric Acid 1 Molar injection, 1 mL vial | Is a | containered trade product pack | true | Inferred relationship | Some | ||
Lymph-Flo Hydrochloric Acid 1 Molar injection, 1 mL vial | has TPUU | Lymph-Flo Hydrochloric Acid 1 Molar injection, vial | true | Inferred relationship | Some | 1 | |
Lymph-Flo Hydrochloric Acid 1 Molar injection, 1 mL vial | has container type | vial | true | Inferred relationship | Some | ||
Lymph-Flo Hydrochloric Acid 1 Molar injection, 1 mL vial | has TP | Lymph-Flo Hydrochloric Acid | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Lymph-Flo (1 x Antimony Trisulfide vial, 1 x Phosphate Buffer vial, 1 x Hydrochloric Acid vial), 1 pack | has component pack | True | Lymph-Flo Hydrochloric Acid 1 Molar injection, 1 mL vial | Inferred relationship | Some |
Reference Sets
Containered trade product pack reference set